{"created":"2023-05-15T09:06:25.582524+00:00","id":13108,"links":{},"metadata":{"_buckets":{"deposit":"ad649420-06d0-4587-8099-8f9c0f2525fd"},"_deposit":{"created_by":14,"id":"13108","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"13108"},"status":"published"},"_oai":{"id":"oai:sapmed.repo.nii.ac.jp:00013108","sets":["1875:1879:1993"]},"author_link":["19787","19788","19789","19790"],"control_number":"13108","item_2_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2014-10","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"32","bibliographicPageStart":"30","bibliographicVolumeNumber":"38","bibliographic_titles":[{"bibliographic_title":"函館医学誌 = Hakodate medical journal"}]}]},"item_2_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"オキシコドン徐放錠(オキシコンチン®)は,わが国で2003年に発売開始となり,現在当院で最も多く処方されているオピオイド鎮痛薬である。適応はがん性の痛みで,小用量の製剤があるため,WHO 方式がん性の痛みの治療法で第2段階から使用可能という特徴がある。 オキシコドン徐放錠は錠剤の骨格が強いため,まれに便中にゴーストピルと呼ばれる脱け殻が排泄されることが知られている1)。しかしその場合,残った錠剤にはきわめてわずかな残量しか検出されず,有効成分はほぼ体内に吸収されているため,特に臨床的な問題は生じないことが報告されている2,3)。他の多くの薬剤と同様,オキシコドン徐放錠も小腸から吸収される。このため小腸皮膚瘻が存在する場合,瘻から排泄されたゴーストピルにどの程度薬剤が残存しているかは明らかでない。 今回われわれは,小腸瘻を有する患者から排泄されたゴーストピルの薬剤含量を測定する機会を得たので報告する。","subitem_description_type":"Abstract"}]},"item_2_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"市立函館病院"}]},"item_2_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0910-0725","subitem_source_identifier_type":"ISSN"}]},"item_2_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"山崎, 裕"}],"nameIdentifiers":[{"nameIdentifier":"19787","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"片山, 貴弘"}],"nameIdentifiers":[{"nameIdentifier":"19788","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"村田, 京子"}],"nameIdentifiers":[{"nameIdentifier":"19789","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"小野, 裕子"}],"nameIdentifiers":[{"nameIdentifier":"19790","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2018-07-21"}],"displaytype":"detail","filename":"n0910-072538130.pdf","filesize":[{"value":"1.5 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"n0910-072538130.pdf","url":"https://sapmed.repo.nii.ac.jp/record/13108/files/n0910-072538130.pdf"},"version_id":"1b11349c-bc0f-4dfd-a6e6-8a4c685c5ff1"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"oxycodone ghost pills","subitem_subject_scheme":"Other"},{"subitem_subject":"enterocutaneous fistula","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"小腸瘻から排泄されたオキシコドン徐放錠ゴーストピルのオキシコドン含量","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"小腸瘻から排泄されたオキシコドン徐放錠ゴーストピルのオキシコドン含量","subitem_title_language":"ja"}]},"item_type_id":"2","owner":"14","path":["1993"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2014-12-10"},"publish_date":"2014-12-10","publish_status":"0","recid":"13108","relation_version_is_last":true,"title":["小腸瘻から排泄されたオキシコドン徐放錠ゴーストピルのオキシコドン含量"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2023-12-13T03:04:16.071809+00:00"}